Ethanol preconditioning protects against ischemia/reperfusion-induced brain damage: Role of NADPH oxidase-derived ROS

Free Radical Biology and Medicine

Volumn 43, Issue 7, 2007, Pages 1048-1060

  Wang, Qun ^a   Sun, Albert Y ^a   Simonyi, Agnes ^a   Kalogeris, Theodore J ^a   Miller, Dennis K ^b   Sun, Grace Y ^a   Korthuis, Ronald J ^a,c  

^a University of Missouri   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

Author keywords

Apocynin; Cerebral ischemia reperfusion; Delayed neuronal death; Ethanol preconditioning; Free radicals; NADPH oxidase; Neuroprotection; Reactive oxygen species

Indexed keywords

4 HYDROXYNONENAL; ALCOHOL; APOCYNIN; NEUROPROTECTIVE AGENT; PROTEIN P67; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; COMMON CAROTID ARTERY; CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVITY; GERBIL; GLIA CELL; HIPPOCAMPUS; LIPID PEROXIDATION; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY;

ANIMALS; BLOTTING, WESTERN; BRAIN ISCHEMIA; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ETHANOL; GERBILLINAE; HIPPOCAMPUS; ISCHEMIC PRECONDITIONING; LIPID PEROXIDATION; MALE; NADPH OXIDASE; NEUROGLIA; NEURONS; OXIDATIVE STRESS; PROTEIN TRANSPORT; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY; TIME FACTORS; TREATMENT OUTCOME;

GERBILLINAE;

EID: 34548126863     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2007.06.018     Document Type: Article

References (77)

1. Truelsen T., and Gronbaek M. Wine consumption and cerebrovascular disease mortality in Spain. Stroke 30 (1999) 186-188
2. German J.B., and Walzem R.L. The health benefits of wine. Annu. Rev. Nutr. 20 (2000) 561-593
3. Rakotovao A., Berthonneche C., Guiraud A., de Lorgeril M., Salen P., de Leiris J., and Boucher F. Ethanol, wine, and experimental cardioprotection in ischemia/reperfusion: role of the prooxidant/antioxidant balance. Antioxid. Redox Signaling 6 (2004) 431-438
4. Ray P.S., Maulik G., Cordis G.A., Bertelli A.A., Bertelli A., and Das D.K. The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury. Free Radic. Biol. Med. 27 (1999) 160-169
5. Wang Q., Xu J., Rottinghaus G.E., Simonyi A., Lubahn D., Sun G.Y., and Sun A.Y. Resveratrol protects against global cerebral ischemic injury in gerbils. Brain Res. 958 (2002) 439-447
6. Sun A.Y., Simonyi A., and Sun G.Y. The "French Paradox" and beyond: neuroprotective effects of polyphenols. Free Radic. Biol. Med. 32 (2002) 314-318
7. Shigematsu S., Ishida S., Hara M., Takahashi N., Yoshimatsu H., Sakata T., and Korthuis R.J. Resveratrol, a red wine constituent polyphenol, prevents superoxide-dependent inflammatory responses induced by ischemia/reperfusion, platelet-activating factor, or oxidants. Free Radic. Biol. Med. 34 (2003) 810-817
8. Sato M., Maulik N., and Das D.K. Cardioprotection with alcohol: role of both alcohol and polyphenolic antioxidants. Ann. N. Y. Acad. Sci. 957 (2002) 122-135
9. Berger K., Ajani U.A., Kase C.S., Gaziano J.M., Buring J.E., Glynn R.J., and Hennekens C.H. Light-to-moderate alcohol consumption and risk of stroke among U.S. male physicians. N. Engl. J. Med. 341 (1999) 1557-1564
10. Reynolds K., Lewis B., Nolen J.D., Kinney G.L., Sathya B., and He J. Alcohol consumption and risk of stroke: a meta-analysis. JAMA 289 (2003) 579-588
11. Miyamae M., Diamond I., Weiner M.W., Camacho S.A., and Figueredo V.M. Regular alcohol consumption mimics cardiac preconditioning by protecting against ischemia-reperfusion injury. Proc. Natl. Acad. Sci. USA 94 (1997) 3235-3239
12. Guiraud A., de Lorgeril M., Boucher F., Berthonneche C., Rakotovao A., and de Leiris J. Cardioprotective effect of chronic low dose ethanol drinking: insights into the concept of ethanol preconditioning. J. Mol. Cell. Cardiol. 36 (2004) 561-566
13. Yamaguchi T., Dayton C.B., Ross C.R., Yoshikawa T., Gute D.C., and Korthuis R.J. Late preconditioning by ethanol is initiated via an oxidant-dependent signaling pathway. Free Radic. Biol. Med. 34 (2003) 365-376
14. Walder C.E., Green S.P., Darbonne W.C., Mathias J., Rae J., Dinauer M.C., Curnutte J.T., and Thomas G.R. Ischemic stroke injury is reduced in mice lacking a functional NADPH oxidase. Stroke 28 (1997) 2252-2258
15. Wang Q., Tompkins K.D., Simonyi A., Korthuis R.J., Sun A.Y., and Sun G.Y. Apocynin protects against global cerebral ischemia-reperfusion-induced oxidative stress and injury in the gerbil hippocampus. Brain Res. 1090 (2006) 182-189
16. Paravicini T.M., and Sobey C.G. Cerebral vascular effects of reactive oxygen species: recent evidence for a role of NADPH-oxidase. Clin. Exp. Pharmacol. Physiol. 30 (2003) 855-859
17. El-Benna J., Dang P.M., Gougerot-Pocidalo M.A., and Elbim C. Phagocyte NADPH oxidase: a multicomponent enzyme essential for host defenses. Arch. Immunol. Ther. Exp. (Warsz) 53 (2005) 199-206
18. Yamaguchi T., Dayton C., Shigematsu T., Carter P., Yoshikawa T., Gute D.C., and Korthuis R.J. Preconditioning with ethanol prevents postischemic leukocyte-endothelial cell adhesive interactions. Am. J. Physiol. Heart Circ. Physiol. 283 (2002) H1019-H1030
19. Dayton C., Yamaguchi T., Kamada K., Carter P., and Korthuis R.J. Antecedent ethanol ingestion prevents postischemic P-selectin expression in murine small intestine. Microcirculation 11 (2004) 709-718
20. Paravicini T.M., Drummond G.R., and Sobey C.G. Reactive oxygen species in the cerebral circulation: physiological roles and therapeutic implications for hypertension and stroke. Drugs 64 (2004) 2143-2157
21. Ishikawa M., Stokes K.Y., Zhang J.H., Nanda A., and Granger D.N. Cerebral microvascular responses to hypercholesterolemia: roles of NADPH oxidase and P-selectin. Circ. Res. 94 (2004) 239-244
22. Ago T., Kitazono T., Kuroda J., Kumai Y., Kamouchi M., Ooboshi H., Wakisaka M., Kawahara T., Rokutan K., Ibayashi S., and Iida M. NAD(P)H oxidases in rat basilar arterial endothelial cells. Stroke 36 (2005) 1040-1046
23. Serrano F., Kolluri N.S., Wientjes F.B., Card J.P., and Klann E. NADPH oxidase immunoreactivity in the mouse brain. Brain Res. 988 (2003) 193-198
24. Kim M.J., Shin K.S., Chung Y.B., Jung K.W., Cha C.I., and Shin D.H. Immunohistochemical study of p47Phox and gp91Phox distributions in rat brain. Brain Res. 1040 (2005) 178-186
25. Wei Y., Sowers J.R., Nistala R., Gong H., Uptergrove G.M., Clark S.E., Morris E.M., Szary N., Manrique C., and Stump C.S. Angiotensin II-induced NADPH oxidase activation impairs insulin signaling in skeletal muscle cells. J. Biol. Chem. 281 (2006) 35137-35146
26. Whaley-Connell A.T., Morris E.M., Rehmer N., Yaghoubian J.C., Wei Y., Hayden M.R., Habibi J., Stump C.S., and Sowers J.R. Albumin activation of NAD(P)H oxidase activity is mediated via Rac1 in proximal tubule cells. Am. J. Nephrol. 27 (2007) 15-23
27. Kruman I., Bruce-Keller A.J., Bredesen D., Waeg G., and Mattson M.P. Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J. Neurosci. 17 (1997) 5089-5100
28. Wang Q., Simonyi A., Li W., Sisk B.A., Miller R.L., Macdonald R.S., Lubahn D.E., Sun G.Y., and Sun A.Y. Dietary grape supplement ameliorates cerebral ischemia-induced neuronal death in gerbils. Mol. Nutr. Food Res. 49 (2005) 443-451
29. Wang Q., Sun A.Y., Simonyi A., Jensen M.D., Shelat P.B., Rottinghaus G.E., MacDonald R.S., Miller D.K., Lubahn D.E., Weisman G.A., and Sun G.Y. Neuroprotective mechanisms of curcumin against cerebral ischemia-induced neuronal apoptosis and behavioral deficits. J. Neurosci. Res. 82 (2005) 138-148
30. Streit W.J. An improved staining method for rat microglial cells using the lectin from Griffonia simplicifolia (GSA I-B4). J. Histochem. Cytochem. 38 (1990) 1683-1686
31. Schmued L.C., Albertson C., and Slikker Jr. W. Fluoro-Jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration. Brain Res. 751 (1997) 37-46
32. Monnerie H., Shashidhara S., and Le Roux P.D. Effect of excess extracellular glutamate on dendrite growth from cerebral cortical neurons at 3 days in vitro: involvement of NMDA receptors. J. Neurosci. Res. 74 (2003) 688-700
33. Won M.H., Kang T.C., Jeon G.S., Lee J.C., Kim D.Y., Choi E.M., Lee K.H., Choi C.D., Chung M.H., and Cho S.S. Immunohistochemical detection of oxidative DNA damage induced by ischemia-reperfusion insults in gerbil hippocampus in vivo. Brain Res. 836 (1999) 70-78
34. Hwang I.K., Yoo K.Y., Kim D.S., Jeong Y.K., Kim J.D., Shin H.K., Lim S.S., Yoo I.D., Kang T.C., Kim D.W., Moon W.K., and Won M.H. Neuroprotective effects of grape seed extract on neuronal injury by inhibiting DNA damage in the gerbil hippocampus after transient forebrain ischemia. Life Sci. 75 (2004) 1989-2001
35. Schlorff E.C., Husain K., and Somani S.M. Dose- and time-dependent effects of ethanol on plasma antioxidant system in rat. Alcohol 17 (1999) 97-105
36. Caceres A., Banker G., Steward O., Binder L., and Payne M. MAP2 is localized to the dendrites of hippocampal neurons which develop in culture. Brain Res. 315 (1984) 314-318
37. Korthuis R.J., Gute D.C., Blecha F., and Ross C.R. PR-39, a proline/arginine-rich antimicrobial peptide, prevents postischemic microvascular dysfunction. Am. J. Physiol. 277 (1999) H1007-H1013
38. Chan Y.R., and Gallo R.L. PR-39, a syndecan-inducing antimicrobial peptide, binds and affects p130(Cas). J. Biol. Chem. 273 (1998) 28978-28985
39. Zalewska T., Makarewicz D., Janik B., and Ziemka-Nalecz M. Neonatal cerebral hypoxia-ischemia: involvement of FAK-dependent pathway. Int. J. Dev. Neurosci. 23 (2005) 657-662
40. Bao J., Sato K., Li M., Gao Y., Abid R., Aird W., Simons M., and Post M.J. PR-39 and PR-11 peptides inhibit ischemia-reperfusion injury by blocking proteasome-mediated I kappa B alpha degradation. Am. J. Physiol. Heart Circ. Physiol. 281 (2001) H2612-H2618
41. Korthuis R.J., Gute D.C., Cepinskas G., and Kvietys P.R. Cellular mechanisms of acute versus delayed preconditioning. Pathophysiology 5 (1998) 35-48
42. Bolli R. Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research. J. Mol. Cell. Cardiol. 33 (2001) 1897-1918
43. Korthuis R.J., and Gute D.C. Adhesion molecule expression in postischemic microvascular dysfunction: activity of a micronized purified flavonoid fraction. J. Vasc. Res. 36 Suppl. 1 (1999) 15-23
44. Stuehr D.J., Fasehun O.A., Kwon N.S., Gross S.S., Gonzalez J.A., Levi R., and Nathan C.F. Inhibition of macrophage and endothelial cell nitric oxide synthase by diphenyleneiodonium and its analogs. FASEB J. 5 (1991) 98-103
45. Yamaguchi, T.; Kamada, K.; Dayton, C.; Gaskin, F. S.; Yusof, M.; Yoshikawa, T.; Korthuis, R. J. Role of eNOS-derived NO in the postischemic anti-inflammatory effects of antecedent ethanol ingestion in murine small intestine. Submitted for publication; 2006.
46. Yamaguchi T., Kamada K., Dayton C., Gaskin F.S., Yusof M., Yoshikawa T., Carter P., and Korthuis R.J. Role of eNOS-derived NO in the postischemic anti-inflammatory effects of antecedent ethanol ingestion in murine small intestine. Am. J. Physiol. Heart Circ. Physiol. 292 (2007) H1435-H1442
47. Engels F., Renirie B.F., Hart B.A., Labadie R.P., and Nijkamp F.P. Effects of apocynin, a drug isolated from the roots of Picrorhiza kurroa, on arachidonic acid metabolism. FEBS Lett. 305 (1992) 254-256
48. Abid M.R., Kachra Z., Spokes K.C., and Aird W.C. NADPH oxidase activity is required for endothelial cell proliferation and migration. FEBS Lett. 486 (2000) 252-256
49. Stolk J., Hiltermann T.J., Dijkman J.H., and Verhoeven A.J. Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol. Am. J. Respir. Cell Mol. Biol. 11 (1994) 95-102
50. Zhou J., Struthers A.D., and Lyles G.A. Differential effects of some cell signalling inhibitors upon nitric oxide synthase expression and nuclear factor-kappaB activation induced by lipopolysaccharide in rat aortic smooth muscle cells. Pharmacol. Res. 39 (1999) 363-373
51. Delbarre B., Delbarre G., and Calinon F. Effect of Daflon 500 mg, a flavonoid drug, on neurological signs, levels of free radicals and electroretinogram in the gerbil after ischemia-reperfusion injury. Int. J. Microcirc. Clin. Exp. 15 Suppl. 1 (1995) 27-33
52. Katsuta K., Umemura K., Ueyama N., and Matsuoka N. Pharmacological evidence for a correlation between hippocampal CA1 cell damage and hyperlocomotion following global cerebral ischemia in gerbils. Eur. J. Pharmacol. 467 (2003) 103-109
53. Gergel D., and Cederbaum A.I. Inhibition of the catalytic activity of alcohol dehydrogenase by nitric oxide is associated with S nitrosylation and the release of zinc. Biochemistry 35 (1996) 16186-16194
54. Gergel D., Misik V., Riesz P., and Cederbaum A.I. Inhibition of rat and human cytochrome P4502E1 catalytic activity and reactive oxygen radical formation by nitric oxide. Arch. Biochem. Biophys. 337 (1997) 239-250
55. Oei H.H., Stroo W.E., Burton K.P., and Schaffer S.W. A possible role of xanthine oxidase in producing oxidative stress in the heart of chronically ethanol treated rats. Res. Commun. Chem. Pathol. Pharmacol. 38 (1982) 453-461
56. Oei H.H., Zoganas H.C., McCord J.M., and Schaffer S.W. Role of acetaldehyde and xanthine oxidase in ethanol-induced oxidative stress. Res. Commun. Chem. Pathol. Pharmacol. 51 (1986) 195-203
57. Sultatos L.G. Effects of acute ethanol administration on the hepatic xanthine dehydrogenase/oxidase system in the rat. J. Pharmacol. Exp. Ther. 246 (1988) 946-949
58. Bailey S.M., Pietsch E.C., and Cunningham C.C. Ethanol stimulates the production of reactive oxygen species at mitochondrial complexes I and III. Free Radic. Biol. Med. 27 (1999) 891-900
59. Bailey S.M., and Cunningham C.C. Contribution of mitochondria to oxidative stress associated with alcoholic liver disease. Free Radic. Biol. Med. 32 (2002) 11-16
60. Becker L.B., vanden Hoek T.L., Shao Z.H., Li C.Q., and Schumacker P.T. Generation of superoxide in cardiomyocytes during ischemia before reperfusion. Am. J. Physiol. 277 (1999) H2240-H2246
61. Chan P.H. Mitochondria and neuronal death/survival signaling pathways in cerebral ischemia. Neurochem. Res. 29 (2004) 1943-1949
62. Chan P.H. Reactive oxygen radicals in signaling and damage in the ischemic brain. J. Cereb. Blood Flow Metab. 21 (2001) 2-14
63. Wu D., and Cederbaum A.I. Alcohol, oxidative stress, and free radical damage. Alcohol Res. Health 27 (2003) 277-284
64. Farwell W., Simonyi A., Scott H., Zhang J.P., Carruthers V., Madsen R., Johnson J., and Sun G.Y. Effects of ischemic tolerance on mRNA levels of IP3R1, beta-actin, and neuron-specific enolase in hippocampal CA1 area of the gerbil brain. Neurochem. Res. 23 (1998) 539-542
65. Schaller B., and Graf R. Cerebral ischemic preconditioning: an experimental phenomenon or a clinically important entity of stroke prevention?. J. Neurol. 249 (2002) 1503-1511
66. Bell R.M., Cave A.C., Johar S., Hearse D.J., Shah A.M., and Shattock M.J. Pivotal role of NOX-2-containing NADPH oxidase in early ischemic preconditioning. FASEB J. 19 (2005) 2037-2039
67. Dayton C., Yamaguchi T., Kamada K., Carter P., and Korthuis R.J. Antecedent ethanol ingestion prevents postischemic leukocyte adhesion and P-selectin expression by a protein kinase C-dependent mechanism. Dig. Dis. Sci. 50 (2005) 684-690
68. Kamada K., Gaskin F.S., Yamaguchi T., Carter P., Yoshikawa T., Yusof M., and Korthuis R.J. Role of calcitonin gene-related peptide in the postischemic anti-inflammatory effects of antecedent ethanol ingestion. Am. J. Physiol. Heart Circ. Physiol. 290 (2006) H531-H537
69. Mori E., del Zoppo G.J., Chambers J.D., Copeland B.R., and Arfors K.E. Inhibition of polymorphonuclear leukocyte adherence suppresses no-reflow after focal cerebral ischemia in baboons. Stroke 23 (1992) 712-718
70. Gidday J.M., Gasche Y.G., Copin J.C., Shah A.R., Perez R.S., Shapiro S.D., Chan P.H., and Park T.S. Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia. Am. J. Physiol. Heart Circ. Physiol. 289 (2005) H558-H568
71. Frijns C.J., and Kappelle L.J. Inflammatory cell adhesion molecules in ischemic cerebrovascular disease. Stroke 33 (2002) 2115-2122
72. Zhang W., and Stanimirovic D. Current and future therapeutic strategies to target inflammation in stroke. Curr. Drug Targets Inflammation Allergy 1 (2002) 151-166
73. Chan P.H. Mitochondrial dysfunction and oxidative stress as determinants of cell death/survival in stroke. Ann. N. Y. Acad. Sci. 1042 (2005) 203-209
74. Sugawara T., and Chan P.H. Reactive oxygen radicals and pathogenesis of neuronal death after cerebral ischemia. Antioxid. Redox Signaling 5 (2003) 597-607
75. Kamada K., Dayton C.B., Yamaguchi T., and Korthuis R.J. Antecedent ethanol ingestion prevents postischemic microvascular dysfunction. Pathophysiology 10 (2004) 131-137
76. Belmadani A., Neafsey E.J., and Collins M.A. Human immunodeficiency virus type 1 gp120 and ethanol coexposure in rat organotypic brain slice cultures: curtailment of gp120-induced neurotoxicity and neurotoxic mediators by moderate but not high ethanol concentrations. J. Neurovirol. 9 (2003) 45-54
77. Belmadani A., Kumar S., Schipma M., Collins M.A., and Neafsey E.J. Inhibition of amyloid-beta-induced neurotoxicity and apoptosis by moderate ethanol preconditioning. Neuroreport 15 (2004) 2093-2096